Comparison among different multiparametric scores for risk stratification in heart failure patients with reduced ejection fraction.


Journal

European journal of preventive cardiology
ISSN: 2047-4881
Titre abrégé: Eur J Prev Cardiol
Pays: England
ID NLM: 101564430

Informations de publication

Date de publication:
12 2020
Historique:
entrez: 26 11 2020
pubmed: 27 11 2020
medline: 12 1 2021
Statut: ppublish

Résumé

Heart failure is a serious condition with high prevalence (about 2% in the adult population in developed countries, and more than 8% in patients older than 75 years). About 3-5% of hospital admissions are linked with heart failure incidents. The guidelines of the European Society of Cardiology for the diagnosis and treatment of acute and chronic heart failure have identified individual markers in patients with heart failure, including demographic data, aetiology, comorbidities, clinical, radiological, haemodynamic, echocardiographic and biochemical parameters. Several scoring systems have been proposed to identify adverse events, such as destabilizations, re-hospitalizations and mortality. This article reviews scoring systems for heart failure prognostication, with particular mention of those models with exercise tolerance objective definition. Although most of the models include readily available clinical information, quite a few of them comprise circulating levels of natriuretic peptides and a more objective evaluation of exercise tolerance. A literature review was also conducted to (a) identify heart failure risk-prediction models, (b) assess statistical approach, and (c) identify common variables.

Identifiants

pubmed: 33238734
doi: 10.1177/2047487320962990
pmc: PMC7691563
doi:

Substances chimiques

Biomarkers 0

Types de publication

Comparative Study Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

12-18

Références

Circulation. 1997 Jun 17;95(12):2660-7
pubmed: 9193435
JACC Heart Fail. 2014 Oct;2(5):429-36
pubmed: 25194294
Am J Cardiol. 2010 May 15;105(10):1439-44
pubmed: 20451691
J Am Coll Cardiol. 2005 Apr 5;45(7):1064-71
pubmed: 15808765
Eur J Heart Fail. 2018 Apr;20(4):711-714
pubmed: 29431287
J Heart Lung Transplant. 2012 Aug;31(8):817-24
pubmed: 22759798
N Engl J Med. 2002 Mar 21;346(12):877-83
pubmed: 11907286
Eur J Heart Fail. 2016 May;18(5):545-53
pubmed: 27135769
J Heart Lung Transplant. 2009 Aug;28(8):827-33
pubmed: 19632580
Eur J Heart Fail. 2016 May;18(5):482-9
pubmed: 27071916
JAMA. 2009 Apr 8;301(14):1439-50
pubmed: 19351941
Heart Lung. 2016 May-Jun;45(3):212-9
pubmed: 27066878
JAMA Netw Open. 2020 Jan 3;3(1):e1918962
pubmed: 31922560
JACC Heart Fail. 2018 Apr;6(4):273-285
pubmed: 29226815
JACC Heart Fail. 2018 Jun;6(6):452-462
pubmed: 29852929
Int J Cardiol. 2013 Sep 10;167(6):2710-8
pubmed: 22795401
Circ Heart Fail. 2012 Jan;5(1):63-71
pubmed: 22114101
Eur J Heart Fail. 2018 Apr;20(4):700-710
pubmed: 28949086
Circulation. 2002 Dec 10;106(24):3079-84
pubmed: 12473555
Eur Heart J. 2013 May;34(19):1404-13
pubmed: 23095984
Heart Fail Rev. 2010 Jul;15(4):331-41
pubmed: 19363700
JACC Heart Fail. 2014 Oct;2(5):440-6
pubmed: 25194291
J Card Fail. 2006 May;12(4):276-80
pubmed: 16679260
Prog Cardiovasc Dis. 2011 Sep-Oct;54(2):86-96
pubmed: 21875508
Am Heart J. 2008 May;155(5):883-9
pubmed: 18440336
Int J Cardiol. 2018 Nov 15;271:301-305
pubmed: 30166068
J Am Coll Cardiol. 2001 Jan;37(1):183-8
pubmed: 11153735
Ann Thorac Surg. 2009 Dec;88(6):1889-96
pubmed: 19932256
Circulation. 2002 May 21;105(20):2392-7
pubmed: 12021226
J Am Coll Cardiol. 2004 Apr 21;43(8):1439-44
pubmed: 15093881
JACC Heart Fail. 2016 Aug;4(8):607-16
pubmed: 27289406
Am J Cardiol. 2017 Aug 1;120(3):443-449
pubmed: 28629552
PLoS One. 2020 Jan 15;15(1):e0224135
pubmed: 31940350
Int J Cardiol. 2013 Oct 3;168(3):2120-6
pubmed: 23395457
Circulation. 2007 Jan 16;115(2):204-12
pubmed: 17190867
Circulation. 2006 Jun 13;113(23):2713-23
pubmed: 16754803
Circ Heart Fail. 2013 Jan;6(1):4-5
pubmed: 23322877
Eur J Prev Cardiol. 2018 Dec;25(18):1937-1946
pubmed: 30247068
Eur J Prev Cardiol. 2019 Jul 26;:2047487319865730
pubmed: 31349775
Am Heart J. 2007 Jan;153(1):74-81
pubmed: 17174642
Circulation. 2005 May 17;111(19):2454-60
pubmed: 15867182
Circ Heart Fail. 2014 Jan;7(1):88-95
pubmed: 24281135
J Heart Lung Transplant. 2015 Aug;34(8):1017-23
pubmed: 25940075
Circulation. 1991 Mar;83(3):778-86
pubmed: 1999029
J Am Coll Cardiol. 2008 Sep 16;52(12):997-1003
pubmed: 18786480
Circulation. 1995 Dec 15;92(12):3593-612
pubmed: 8521589
Circ Heart Fail. 2013 Sep 1;6(5):881-9
pubmed: 23888045
Circulation. 2005 Dec 13;112(24):3738-44
pubmed: 16330684
Circulation. 2007 Aug 7;116(6):627-36
pubmed: 17638930
J Am Coll Cardiol. 2003 Jun 4;41(11):1933-9
pubmed: 12798560
J Heart Lung Transplant. 2017 Oct;36(10):1080-1086
pubmed: 28942782
Circulation. 2006 Mar 21;113(11):1424-33
pubmed: 16534009
J Card Fail. 2003 Jun;9(3):180-7
pubmed: 12815567

Auteurs

Ugo Corrà (U)

IRCCS Istituti Clinici Scientifici Maugeri Spa SB, Italy.

Alessandra Magini (A)

Centro Cardiologico Monzino IRCCS, Italy.

Stefania Paolillo (S)

Department of Advanced Biomedical Sciences, Federico II University of Naples, Italy.

Maria Frigerio (M)

DeGasperis CardioCenter, Niguarda Hospital, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH